Ofertă pentruImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml
Date procedură de achiziție
Titlu
Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2024 (repetat nr. 3)
Beneficiar
CENTRUL PENTRU ACHIZITII PUBLICE CENTRALIZATE IN SANATATE
Descriere
Achiziționarea medicamentelor oncologice şi imunosupresive necesare instituţiilor medico-sanitare publice (IMSP) pentru anul 2024 (repetat nr. 3)
Valoare achiziție
4,851,510.60 MDL
Perioadă de depunere oferte
2023-10-27 16:00:00 - 2023-11-03 12:00:00
Ofertă
Lot
Obiect achiziție
Valoare lot
Valuta
Valoare ofertă, fără TVA
Immunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml
Immunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml
Publicată la data: 03/11/2023 11:52
Documente
DataNumeTipReferințaDescriereLimba
07/11/2023 17:3410cereredeparticiparesigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml10cereredeparticiparesigned.pdfRomana
07/11/2023 17:3420declaratieprivindvalabilitateaoferteisigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml20declaratieprivindvalabilitateaoferteisigned.pdfRomana
07/11/2023 17:3440propunereatehnicăsigned.pdfPropunere tehnicăImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml40propunereatehnicăsigned.pdfRomana
07/11/2023 17:3450propunereafinanciarăsigned.pdfPropunere financiarăImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml50propunereafinanciarăsigned.pdfRomana
07/11/2023 17:3470licentaafsigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml70licentaafsigned.pdfRomana
07/11/2023 17:3480certificatdeinregistraresigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml80certificatdeinregistraresigned.pdfRomana
07/11/2023 17:3490extrasdinregistrusigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml90extrasdinregistrusigned.pdfRomana
07/11/2023 17:34100raportfinanciar2022signed.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml100raportfinanciar2022signed.pdfRomana
07/11/2023 17:34110listafondatorilorsigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml110listafondatorilorsigned.pdfRomana
07/11/2023 17:34120certificatsfssigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml120certificatsfssigned.pdfRomana
07/11/2023 17:34130certificatmaibsigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml130certificatmaibsigned.pdfRomana
07/11/2023 17:34140declaratietermensigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml140declaratietermensigned.pdfRomana
07/11/2023 17:34biotestpharmagmpsigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 mlbiotestpharmagmpsigned.pdfRomana
07/11/2023 17:34cppsigned.pdfDoc. de calificareImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 mlcppsigned.pdfRomana
03/11/2023 14:0030gbsignedsigned.pdfGaranțiiImmunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml30gbsignedsigned.pdfRomana
03/11/2023 14:0060duaesigned.pdfDoc. de eligibilitate (DUAE)Immunoglobulinum humanum antihepaticum (pu terapia post-transplant) 2000 UI 40 ml60duaesigned.pdfRomana